[Therapeutic policy in stage I-II laryngeal cancer].
Radio-, chemoradiation (with making use of cysplatin and 5-fluorouracil) therapies were employed together with a surgical method as treatment of 197 patients with T1-2N0M0 laryngeal cancer. Efficiency of the methods each was assessed by recurrence-free source of the disease, survivals, and by functional results as well. The best results in the treatment of T1N0M0 laryngeal cancer have been found out to be secured with the use of the surgical method, as evidenced by the analysis of the clinical material--94.3 percent of patients are free from recurrence and metastases for more than three years versus 81.6 percent with the radiotherapy method. In T2N0M0 laryngeal cancer, 70% of patients are free from recurrence and metastases after radiotherapy treatments. With chemoradiotherapy and surgical treatment these parameters comprised 88.8% and 11.2%; 91.5% and 8.5%. In T2N0M0 glottic cancer the surgical method is considered to be superior to other options.
Amiraliev
N M
NM
D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D015996:Survival Rate
O lechebnoĭ taktike pri rake gortani I-II stadii.